Visfatin as a predictor for growth of fetus and infant

Journal Title: Turkish Journal of Obstetrics and Gynecology - Year 2018, Vol 15, Issue 2

Abstract

Objective: Visfatin is an adipocytokine that functions as an enzyme and a growth factor to investigate the relationship between serum visfatin and the fetus’s anthropometric markers up to a year after birth. Materials and Methods: Forty-one eligible pregnant women in their first trimester were divided and matched in terms of body mass index (BMI) before pregnancy into normal and higher than normal BMI groups, A and B. Serum visfatin levels were measured during 6-12 and 15-20 weeks of gestation using ELISA. Results: The infants were followed up for a mean duration of 10.19±2.83 months. In group A, there was a strong positive relationship between birth head circumference and the first (p1=0.054, r1=0.580) and second trimester visfatin levels (p2=0.051, r2=0.530). In group B, second trimester visfatin levels correlated negatively with birth length (p=0.015, r=-0.523) and infant’s head circumference (p2=0.050, r2=-0.392). In a separate study on group B, visfatin levels in the first and second trimesters showed a significant negative correlation with infant’s weight. A significant correlation was observed between the first and second trimesters visfatin level with infant’s height in both groups, such that this relationship was positive in group A and negative in group B. Linear regression analysis revealed that first and second trimester visfatin levels were significant independent predictors of infant’s weight in group B and infant’s height in both groups. Second trimester visfatin level was a significant predictor of birth height in group B. Conclusion: Maternal serum visfatin level shows a relationship with fetal and infant anthropometric indicators, with different effects in the two groups, suggesting visfatin dysfunction in the overweight group before pregnancy.

Authors and Affiliations

Ashraf Saber Mashhad Taraqi, Najmeh Tehranian, Marzieh Faghani Aghoozi, Somayeh Yousefi, Anoshirvan Kazemnejad, Shiva Pourali Roudbaneh, Matin Sadat Esmaeilzadeh

Keywords

Related Articles

Early-onset neonatal infection in pregnancies with prelabor rupture of membranes in Kosovo: A major challenge

Objective: Prelabor rupture of membranes (PROM) is a common event in obstetrics that has a major impact in pregnancy outcome. This condition is linked to a number of pregnancy and birth complications with early-onset neo...

Role of less commonly agreed risk factors on disease recurrence in endometrial cancer: a propensity scorematched comparison

Objective: To compare the clinicopathologic features of patients with endometrial cancer (EC) with recurrent disease with a primary surgery, stage, grade, and tumor histotype-matched cohort of patients without recurrence...

Management of vesicovaginal fistulas after gynecologic surgery

Objective: In developed nations, surgery, especially gynecologic procedures, is the major cause of vesicovaginal fistulas (VVFs). We retrospectively evaluated our treatment modalities for VVF repair caused by a gynecolog...

Fetomaternal outcomes in pregnant women with hepatitis E infection; still an important fetomaternal killer with an unresolved mystery of increased virulence in pregnancy

Objective: Hepatitis is a prevalent infection in developing countries. While hepatitis B and C are deepening their roots in the developed world, hepatitis A and E are common in the developing world. The uniqueness of hep...

Features of ovarian Brenner tumors: Experience of a single tertiary center

Objective: Brenner tumors are rare neoplasms of the ovary. The aim of this study was to investigate the clinical features of Brenner tumors. Materials and Methods: The clinical features of 22 patients who were treated i...

Download PDF file
  • EP ID EP365338
  • DOI 10.4274/tjod.48091
  • Views 97
  • Downloads 0

How To Cite

Ashraf Saber Mashhad Taraqi, Najmeh Tehranian, Marzieh Faghani Aghoozi, Somayeh Yousefi, Anoshirvan Kazemnejad, Shiva Pourali Roudbaneh, Matin Sadat Esmaeilzadeh (2018). Visfatin as a predictor for growth of fetus and infant. Turkish Journal of Obstetrics and Gynecology, 15(2), 80-86. https://europub.co.uk/articles/-A-365338